Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy

Quanticyt: Karyometric analysis of bladder washing for patients with superficial bladder cancer

“…Recently, the selection of which patients should undergo this invasive investigation was under analysis. 6 The identification of patients at higher risk for tu mor recurrence or progression was based on mul tiplicity and the presence of tumor recurrence at 3 months after transurethral resection. QUANTI-CYT in combination with these clinical data, aids in defining patients at risk, and in need for fre quent cystoscopy.…”

“…Hall et al 6 proposed a follow-up scheme based on the initial clinical prognostic findings as found by Kurth et a l3 Cystoscopy frequency in patients at low risk for tumor progression could be signifi cantly reduced.6 So far, however, these recom mendations have not been applied on a wide scale.…”

Repeat Testing Among Medicare Beneficiaries

“…13 Our repeat cystoscopy findings confirm those expected by the American Urological Association, despite repeated suggestions that most patients would do well with less intensive surveillance. 14,15 The finding that almost one-third of upper endoscopies were repeated within 3 years was considerably higher than we expected.…”

Early and large‐dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection

“…However, a relatively high recurrence rate and risk of progression to invasive cancer are important issues during the follow-up of these patients [2]. Tumour implantation and incomplete resection are reasons for the relatively high tendency to recurrence [3].…”